Get started
Author

Shuyi Tang

ORCID: 0009-0001-2870-5331
Observed ORCID: 0009-0001-2870-5331
OpenAlex ID: A5047712759
Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2024 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al. · Molecular Cancer Therapeutics · 2
Figure S5 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S3 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Figure S3 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Figure S2 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Figure S4 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Figure S8 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Figure S1 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S6 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Figure S6 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S2 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S1 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S4 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S9 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Figure S7 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S8 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S5 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S7 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2026 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Data from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2024 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S8 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2024 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Figure S2 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2024 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Supplementary Data from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2024 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Figure S4 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2024 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S9 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2024 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Table S8 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates
2024 · Joshua D. Thomas, Aleksandr V. Yurkovetskiy, et al.
Works count: 51
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type